Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Exploration on the first-line treatment of ERBB2-altered advanced non-small cell lung cancer: A multicenter retrospective study

Published:2023-09 Issue: Volume:183 Page:107315
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Chen Jiayan,Xu Chunwei,Wang Qian,Lv Jiawen,Lu Wanjun,Zhang Yixue,Yao Yanwen,Gu Xiaoling,Wu Guannan,Hao Yue,Pan Weiwei,Wang Wenxian,Zhang Shirong,Lv Tangfeng,Song Yong^ORCID,Wang Dong

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference42 articles.

1. GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung;CA Cancer J. Clin.,2021

2. Transformation from non-small-cell lung cancer to small-cell lung cancer: molecular drivers and cells of origin;Oser;Lancet Oncol.,2015

3. Chinese expert consensus on the diagnosis and treatment of HER2-altered non-small cell lung cancer;Zhang;Thorac. Cancer,2022

4. Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives;Mazieres;J. Clin. Oncol.,2013

5. HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers;Li;J. Thorac. Oncol.,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A retrospective study of first‐line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations;Cancer Medicine;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP